ARCHIVES

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

NCI Division To Promote Funds To Promote Collaboration.

February 18, 2000

New Version Of NCI Proposed IP Agreement Quiets Some Unease At Cooperative Groups; Advisors Urge “No Paralysis” While Awaiting New Language

November 13, 2009

ELM Wins ACCC Management Contract Over ORC, Others

February 21, 1992

Seventeen New ACS-Roosevelt Grants Awarded

July 25, 1975

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979